🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 7 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/11/2017 40,50 42,35 38,92 42,20 +4,84% 8,47% 1.246.400
17/11/2017 39,40 40,80 39,25 40,25 +1,90% 3,93% 716.000
16/11/2017 39,15 40,05 38,70 39,50 +1,99% 3,45% 643.300
15/11/2017 39,25 39,25 37,80 38,73 -2,98% 3,69% 858.700
14/11/2017 42,40 42,40 38,33 39,92 -6,62% 9,60% 1.638.900
13/11/2017 41,65 43,30 41,20 42,75 +1,66% 5,04% 1.183.100
10/11/2017 39,85 42,15 39,68 42,05 +4,73% 6,20% 787.400
09/11/2017 41,15 41,30 39,40 40,15 -2,07% 4,62% 978.700
08/11/2017 39,50 43,60 37,65 41,00 +16,98% 15,06% 2.743.900
07/11/2017 36,20 36,20 34,95 35,05 -3,44% 3,45% 970.800
06/11/2017 35,90 37,00 35,80 36,30 +0,55% 3,34% 580.900
03/11/2017 33,80 36,56 33,75 36,10 +9,23% 8,31% 1.282.000
02/11/2017 32,70 33,75 32,33 33,05 +1,38% 4,34% 824.800
01/11/2017 32,40 33,30 32,20 32,60 +1,72% 3,40% 797.500
31/10/2017 33,00 33,28 31,85 32,05 -3,32% 4,33% 1.059.300
30/10/2017 31,85 33,50 31,50 33,15 -0,15% 6,28% 1.023.800
27/10/2017 32,65 33,45 32,35 33,20 +2,00% 3,37% 1.067.300
26/10/2017 30,25 32,75 29,81 32,55 +2,20% 9,72% 1.392.900
25/10/2017 32,95 33,15 31,71 31,85 -4,64% 4,37% 861.100
24/10/2017 33,10 33,90 32,75 33,40 +1,37% 3,47% 759.000
23/10/2017 33,45 33,70 32,90 32,95 -1,64% 2,39% 508.400
20/10/2017 33,45 33,90 33,15 33,50 +1,21% 2,24% 481.200
19/10/2017 33,00 33,40 32,65 33,10 +0,15% 2,27% 473.600
18/10/2017 34,25 34,80 33,00 33,05 -3,36% 5,26% 799.700
17/10/2017 34,30 34,60 33,85 34,20 -1,01% 2,19% 703.700
16/10/2017 34,20 35,45 34,20 34,55 +0,88% 3,65% 488.300
13/10/2017 34,05 34,45 33,75 34,25 +0,15% 2,06% 747.000
12/10/2017 34,20 34,54 33,45 34,20 -0,58% 3,19% 694.700
11/10/2017 34,80 34,95 33,95 34,40 -1,57% 2,87% 606.300
10/10/2017 35,15 35,60 34,25 34,95 -0,29% 3,84% 507.100